Gary L. Norman

Overview

Best Publications

• Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

  Minoru Nakamura;Hisayoshi Kondo;Tsuyoshi Mori;Atsumasa Komori

  471
  Citations

• New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

  Marc Ferrante;Liesbet Henckaerts;Marie Joossens;Marie Pierik

  375
  Citations

• Autoimmune acute liver failure: proposed clinical and histological criteria.

  R. Todd Stravitz;Jay H. Lefkowitch;Robert J. Fontana;M. Eric Gershwin

  334
  Citations

• AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

  Kentaroh Yamamoto;Hiroshi Imamura;Yutaka Matsuyama;Yukio Kume

  280
  Citations

• New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.

  Mária Papp;István Altorjay;Nir Dotan;Károly Palatka

  204
  Citations

• IL-2 receptor alpha deficiency and features of primary biliary cirrhosis.

  Christopher A Aoki;Chaim M Roifman;Zhe-Xiong Lian;Christopher L Bowlus

  199
  Citations

• Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency.

  Edith Lahner;Gary L Norman;Carola Severi;Susan Encabo

  187
  Citations

• Utility of serological markers in inflammatory bowel diseases: gadget or magic?

  Maria Papp;Gary L Norman;Istvan Altorjay;Peter Laszlo Lakatos

  166
  Citations

• Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.

  Shervin Assassi;Marvin J. Fritzler;Frank C. Arnett;Gary L. Norman

  155
  Citations

• Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis

  Patrick S C Leung;Lorenzo Rossaro;Paul A. Davis;Ogyi Park

  149
  Citations

• PBC Screen An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis

  Haiying Liu;Gary L. Norman;Zakera Shums;Howard J. Worman

  148
  Citations

• Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.

  Laura Andreoli;Cecilia B. Chighizola;Cecilia Nalli;Maria Gerosa

  129
  Citations

• Value of Isolated IgA Anti–β2‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome

  Vijaya Murthy;Rohan Willis;Rohan Willis;Zurina Romay-Penabad;Patricia Ruiz-Limõn;Patricia Ruiz-Limõn

  127
  Citations

• Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their ‘innocent’ profile?

  Laura Andreoli;Cecilia Nalli;Mario Motta;Gary L. Norman

  127
  Citations

• Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients

  Maria Papp;Istvan Altorjay;Gary L. Norman;Zakera Shums

  127
  Citations

• Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome.

  Michael Mahler;Gary L. Norman;Pier Luigi Meroni;Munther Khamashta

  123
  Citations

• The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies

  Masanobu Tsuda;Troy R. Torgerson;Carlo Selmi;Eleonora Gambineri

  120
  Citations

• Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.

  Hui Shi;Hui Zheng;Yu-Feng Yin;Qiong-Yi Hu

  120
  Citations

• Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.

  Navid Zohoury;Maria Laura Bertolaccini;Jose Luis Rodriguez-Garcia;Zakera Shums

  117
  Citations

• Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of β2-GPI

  G. Michael Iverson;Carlos A. von Mühlen;Henrique L. Staub;Andrew J. Lassen

  102
  Citations